Medical management of Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 72, Issue SUPPL. 1, 2002, Pages

  Clarke, C E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DELAYED RELEASE FORMULATION; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; NEUROPROTECTIVE AGENT;

CLINICAL TRIAL (TOPIC); DELAYED RELEASE FORMULATION; DRUG EFFECTS; HUMAN; NEUROLOGIC EXAMINATION; PARKINSON DISEASE;

AMANTADINE; CHOLINERGIC ANTAGONISTS; CLINICAL TRIALS AS TOPIC; DELAYED-ACTION PREPARATIONS; DOPAMINE AGONISTS; HUMANS; LEVODOPA; NEUROLOGIC EXAMINATION; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE;

EID: 0036186197     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.72.suppl-1.i22     Document Type: Review

References (10)

1. Schapira AHV. Parkinson's disease. BMJ 1999;318:311-14. Contains a valuable summary of issues regarding neuroprotection.
2. Clarke CE. Does levodopa therapy delay death in Parkinson's disease? A review of the evidence. Mov Disord 1995;10:250-6.
3. Ben-Shlomo Y, Churchyard A, Head J, et al. Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry. BMJ 1998;316:1191-6. (Pubitemid 28171332)
4. Ramaker C, van Hilten J. Bromocriptine versus levodopa in early Parkinson's disease. The Cochrane Library. Oxford: Update Software, 2000. One of the many useful systematic reviews of treatment in the Cochrane Library.
5. Ramaker C, van Hilten J. Bromocriptine/levodopa versus levodopa in early Parkinson's disease. Parkinsonism and Related Disorders 1999;5(suppl):82.
6. Parkinson Study Group. Pramipexole versus levodopa as initial treatment for Parkinson's disease. JAMA 2000;284:1931-8.
7. Rascol O, Brooks D, Korczyn A, et al. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med 2000;342:1484-91. Two pivotal monotherapy trials with modern dopamine agonists.
8. Frankel JP, Lees AJ, Kempster PA, et al. Subcutaneous apomorphine in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry 1990;53:96-101. (Pubitemid 20067654)
9. Bhatia K, Brooks D, Burn D, et al. Guidelines for the management of Parkinson's disease. Hospital Medicine 1998;59:469-80. (Pubitemid 128724351)
10. Olanow C, Watts R, Koller W. An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. Neurology 2001;56(suppl 5):S1-88. Two sets of management guidelines presenting therapeutic options but few answers.